NanoGroup S.A. (WSE:NNG)

Market Cap	86.05M
Revenue (ttm)	100.00
Net Income (ttm)	-5.69M
Shares Out	31.64M
EPS (ttm)	-0.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,149
Average Volume	28,836
Open	2.720
Previous Close	2.720
Day's Range	2.680 - 2.790
52-Week Range	2.060 - 4.340
Beta	0.79
RSI	54.71
Earnings Date	Sep 19, 2025

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Country: Poland
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NNG

Financial Performance

In 2024, NanoGroup's revenue was 2,100, an increase of 4.01% compared to the previous year's 2,019. Losses were -5.17 million, -34.50% less than in 2023.